A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 Treatment in Patients with Relapsed And/or Refractory Peripheral T-cell Lymphoma
Journal of Hematology & Oncology(2025)
Key words
Peripheral T-cell lymphoma,EZH1/2,HH2853
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined